CONy 2023 | Effects of menopause in women with MS: Cervantes scale

Multiple sclerosis (MS) is typically diagnosed in young adulthood, and a majority of women living with MS will undergo menopause after MS diagnosis. Celia Oreja-Guevara, MD, PhD, University Hospital San Carlos, Madrid, Spain, discusses the quality of life in menopausal women with MS. Since the advent of disease-modifying therapies (DMTs), the life expectancy and median age of patients living with MS has increased, thereby necessitating awareness among clinicians of the changing needs associated with older patients. A study used the Cervantes Scale, a tool to measure health-related quality of life in perimenopausal and menopausal women, to compare the quality of life between menopausal women with MS and menopausal women without MS. Researchers found that MS patients performed better on certain scale domains such as psychic and vasomotor symptoms. Because symptoms of MS and menopause can frequently overlap, MS patients don’t experience a decrease in quality of life during menopause. This interview took place at the 17th World Congress on Controversies in Neurology (CONy) in Dubrovnik, Croatia.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.